Login
From:
Neuromyelitis News
(Uncensored)
subscribe
Low Rituximab Dose Effective at Preventing Relapses in NMOSD: Analysis | Treatment Over 3 Weeks Also Found to Reduce Disability Progression | Neuromyelitis News
https://neuromyelitisnews.com/news/low-rituximab-dose-effective-preventing-relapses-nmosd/
links
backlinks
Tagged with:
meta-analysis
relapse prevention
disability progression
low dose rituximab
Three weeks of low-dose rituximab was found to prevent relapses and disability progression in NMOSD patients, without serious side effects.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
